WALTHAM, Mass., May 27, 2020 /PRNewswire/ -- Thermo
Fisher Scientific Inc. (NYSE: TMO), the world leader in serving
science, will provide online programming and virtual exhibits to
introduce scientists to a number of new products that build on its
leading Orbitrap platform and expand research
applications.
The company will showcase its newest instruments, software and
workflow solutions during a company-hosted virtual event,
vLC-MS.com, from May 26-28, 2020, and
at the American Society for Mass Spectrometry (ASMS) Reboot
Program, from June 1-12, 2020.
"The need for accelerated research has been heightened during
the pandemic, and the public is expecting unprecedented progress
from the scientific community," said Dan
Shine, senior vice president and president, analytical
instruments. "A deeper analysis of proteins is critical to
understanding disease, including novel viruses. New instruments,
software and workflows can power discovery, improve productivity
and enable breakthroughs across everything from small molecule
studies to metaproteomics and biotherapeutics discovery."
Expanding options for high-performance mass
spectrometry
The new Thermo Scientific Orbitrap Exploris 240 mass
spectrometer expands the proven Orbitrap Exploris platform and is
designed to give scientists working in proteomics, metabolomics,
biopharmaceutical characterization and small-molecules, the
analytical performance required for research and high-throughput
analyses. The new system will advance discovery and identification
with increased accuracy for confident scale-up, while providing
operational simplicity and streamlining time-to-result.
In addition, the new Thermo Scientific Orbitrap Exploris 120
mass spectrometer delivers demonstrated qualitative and
quantitative capabilities synonymous with Orbitrap high-resolution
accurate-mass (HRAM) spectrometry, with internal calibration that
assures consistent data quality and decision making. The new
instrument is designed to deliver proven measurement capabilities
in a system developed for increased productivity.
These newest systems extend the Thermo Scientific Orbitrap
Exploris portfolio of HRAM systems, which were introduced in 2019
with the release of the new-generation Thermo Scientific Orbitrap
Exploris 480 mass spectrometer.
Enhancing software for improved confidence, productivity and
versatility
Thermo Scientific Proteome Discoverer 2.5 software provides
high confidence during peptide identification, more accurate
quantification and higher throughput data analysis for proteomics
researchers. Deep learning-based prediction of tandem mass spectra,
facilitated through a new collaboration with MSAID GmbH, a software
company transforming proteomics through deep learning, allows more
scientists to benefit from vast improvements in identification
confidence and reproducibility.
To further enhance characterization or protein biotherapeutics
and oligonucleotide therapeutics, biopharmaceutical laboratories
now use the Thermo Scientific BioPharma Finder 4.0 software, which
provides greater flexibility and customization for this growing
industry.
For small molecule researchers, Thermo Scientific Compound
Discoverer 3.2 software further automates unknown compound
identification performed on Thermo Scientific Orbitrap Gas
Chromatography-Mass Spectrometry (GC-MS) systems to improve
productivity. Lastly, new Thermo Scientific Xcalibur 4.4 software
brings the AcquireX intelligent data acquisition
workflow to Thermo Scientific Orbitrap Exploris mass
spectrometry platform users, enabling the fully automated
acquisition of high quality MS/MS data and reducing manual input
and repeat runs.
Collaborating to improve proteomic workflows
A continued collaboration with Evosep, a leading provider of
sample preparation technologies for protein-based clinical
research, supports the development of high-throughput clinical
research workflows for profiling large plasma sample cohorts for
proteomics, translational research and pharmaceutical applications.
This partnership recently led to the launch of an automated
ultra-high throughput plasma protein profiling platform, combing
the power of the new Thermo Scientific Orbitrap Exploris 240 mass
spectrometer with the Evosep One liquid chromatography
solution.
The expanded collaboration with Biognosys, a leading developer
of next-generation proteomics solutions, resulted in the
development of data-independent acquisition mass spectrometry-based
workflows, improving sensitivity and coverage for proteomic
research in translational and clinical labs. The collaboration
includes a novel FAIMS-DIA method that features the Thermo
Scientific FAIMS Pro interface, which improves selectivity,
reproducibility and proteome coverage, as well as new methods
that streamline discovery by combining Thermo Scientific SureQuant
Targeted Assay Kits and the Biognosys PQ500 kit in a single
workflow.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving
science, with annual revenue exceeding $25
billion. Our Mission is to enable our customers to make the
world healthier, cleaner and safer. Whether our customers are
accelerating life sciences research, solving complex analytical
challenges, improving patient diagnostics and therapies or
increasing productivity in their laboratories, we are here to
support them. Our global team of more than 75,000 colleagues
delivers an unrivaled combination of innovative technologies,
purchasing convenience and pharmaceutical services through our
industry-leading brands, including Thermo Scientific, Applied
Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and
Patheon. For more information, please visit
www.thermofisher.com.
Media Contact Information:
Charlotte McCormack
Phone: 781-622-1202
E-mail: charlotte.mccormack@thermofisher.com
Investor Contact Information:
Ken Apicerno
Phone: 781-622-1294
E-mail: ken.apicerno@thermofisher.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/thermo-fisher-scientific-to-showcase-new-mass-spectrometry-systems-and-software-during-virtual-asms-event-301065672.html
SOURCE Thermo Fisher Scientific